[1]
“Efficacy Of Loralatinib In Combination With Alectinib In Patients With Anaplastic Kinase-Positive Small Cell Lung Cancer With Moderate Lung Disease: A Case Report”, Clinical and Medical Case Reports, vol. 2, no. 01, pp. 34–37, Jan. 2022, Accessed: Jan. 22, 2025. [Online]. Available: https://currentopinion.info/index.php/cmcr/article/view/77